Ấn Độ không quan ngại về tác dụng phụ của vaccine AstraZeneca

(TTXVN/Vietnam+) 08:12 18/03/2021

Ngày 17/3, quan chức y tế Ấn Độ Vinod Kumar Paul khẳng định rằng nước này không lo ngại về tác dụng phụ tiềm ẩn của vaccine AstraZeneca đang được sử dụng trong chương trình tiêm chủng quốc gia.

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